Ấn Độ không quan ngại về tác dụng phụ của vaccine AstraZeneca

(TTXVN/Vietnam+) 08:12 18/03/2021

Ngày 17/3, quan chức y tế Ấn Độ Vinod Kumar Paul khẳng định rằng nước này không lo ngại về tác dụng phụ tiềm ẩn của vaccine AstraZeneca đang được sử dụng trong chương trình tiêm chủng quốc gia.

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